Verisys is excited to welcome Valerie Mondelli as Chief Revenue Officer. Mondelli will lead Verisys into its next stage of growth through sales, revenue leadership and accelerating brand equity. She is firmly poised to leverage her 15 years of experience with McKesson and Verisys' 25 years of health care market-specific leadership and expertise. Verisys is at the forefront of the health care industry with its offerings of health care data and highly sophisticated SaaS solutions that address credentialing, compliance, patient safety and prescriber monitoring solutions.
While at McKesson, Mondelli led the sales and marketing functions at RelayHealth. Her tenure at McKesson demonstrates her abilities to drive exceptional business development results through sales management, marketing and account management. She is fluent across diverse markets including health care information technology, financial network services, and pharmaceutical vertical markets. Her reputation is unmatched when it comes to developing high-performing teams, cultivating enduring customer relationships and generating top-line growth through innovation and the introduction of new solutions.
John Benson, Verisys co-founder and CEO, says, "We are incredibly excited to bring Valerie on board. She has a stellar reputation in health care and while at McKesson, she partnered with national retailers, pharmaceutical manufacturers, payers and providers to solve complex challenges facing the health care market." He continues, "Valerie is known for consistently building best-in-class sales cultures and winning teams because she is a strategic leader with many years of experience across most sectors of the health care industry. We are looking forward to having her join the executive team."
Mondelli shares John's enthusiasm and says, "I am excited to join John and the Verisys team. In today's highly regulated health care arena, Verisys and its market-leading, end-to-end platform alleviates compliance risks and administrative burdens by ensuring all providers are properly licensed, fully compliant, and meet all credentialing best-practices criteria. Verisys has an unmatched reputation in the market for being the gold standard data provider for all organizations that need to meet strict compliance standards and is focused on developing the next generation compliance platform for all health care stakeholders."
Mondelli has an MBA from Georgia State University, holds a pharmacy degree from West Virginia University and is a registered pharmacist. Before McKesson, she worked at Eli Lilly & Company and then held management positions at Derivion and CheckFree Corporation—both in the online banking and bill pay space.
She was a Presidential Scholar at WVU and has been named one of the Top 100 Sales Leaders & Operations Executives in the U.S. Mondelli is a national Trustee with the Boys and Girls Clubs of America and serves on boards that align with her commitment to community.
Verisys' mission is to provide a comprehensive technology platform of data, analytics and services that deliver value to the full spectrum of organizations in the health care sector. Verisys' vision is to protect health care consumers by enforcing competency and patient safety through transparency. As stewards of provider data and credentials, Verisys is dedicated to mitigating legal, financial and regulatory risk for its clients and their end-users. We prevent fraud, waste and abuse in health care with accurate and timely data on individuals, professionals and businesses (for contracting, privileging, employment, reimbursement and referral validation).
FACIS® is Verisys' flagship data set containing 8 million records and is the gold standard for exclusion, debarment, sanction and disciplinary action screening and monitoring. FACIS® is timely and accurately curated from well over 5,000 nationwide full taxonomy primary sources for flawless screening, verifications and monitoring, ensuring full regulatory compliance.
INSIGHT™ data sets provide detailed visibility into a provider's credentials and risk factors, beyond FACIS®. INSIGHT™ primary sources include National Professional Licensure, DEA Registrant, State Controlled Substance, NPI, PECOS Enrollment, National Abuse Registry, OFAC+, SSA-DMF, National Sex Offender and Address Watch.
CheckMedic® is Verisys' advanced credentialing and standard setting organization compliance platform—an integrated workflow and monitoring solution that ensures all individuals and entities are properly licensed, certified, registered, fully compliant, and meet regulatory best-practices criteria. This end-to-end, cloud-based SaaS tool increases productivity, lowers costs, reduces administrative burden and elevates accuracy. CheckMedic® is exclusively endorsed by the American Hospital Association.
ProviderCheck® is Verisys' transactional prescriber and provider verification and monitoring solution that issues pass/fail decisioning at the time of dispensing or reimbursement for transparent processing, eliminating non-reimbursable events, loss of inventory, loss of revenue and potential abuse and fines. ProviderCheck® is one of the most effective transactional tools to expose the bad actors at the heart of the opioid abuse crisis.
The Verisys team handles millions of transactions annually across the health care sector. Our clients include hospital systems, clinics, labs, pharmacies, pharmaceutical manufacturers, independent provider groups, dental and chiropractic practices, medical equipment manufacturers (DME), payers, managed care organizations, medical malpractice carriers, background screening companies and credentialing organizations.
Verisys is one of only a few Credential Verification Organizations both URAC Accredited and NCQA certified.
For 25 years, Verisys has delivered highly secure technology solutions for some of the largest health care delivery and support organizations in the country. Our partners and clients regularly express resounding confidence in our ability to deliver and delight and provide leadership and direction in the ever-evolving health care compliance environment in the United States.
Earlier this year, Verisys was acquired by Spectrum Equity with co-investments from CEO John Benson and Cressey & Company.